Related Experiment Video
Updated: Sep 3, 2025

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Sex Differences in Taxane Toxicities
Nicole N Chmielewski1, Charles L Limoli1
1Department of Radiation Oncology, University of California, Irvine, CA 92697, USA.
Abstract:
The taxane family of microtubule poisons and chemotherapeutics have been studied for over 50 years and are among the most frequently used antineoplastic agents today. Still, limited research exists characterizing taxane-induced sex-specific mechanisms of action and toxicities in cancer and non-cancerous tissue. Such research is important to advance cancer treatment outcomes as well as to address clinically observed sex-differences in short- and long-term taxane-induced toxicities that have disproportionate effects on female and male cancer patients. To gain more insight into these underlying differences between the sexes, the following review draws from pre-clinical and clinical paclitaxel and taxane oncology literature, examines sex-discrepancies, and highlights uncharacterized sex-dependent mechanisms of action and clinical outcomes. To our knowledge, this is the first literature review to provide a current overview of the basic and clinical sex dimorphisms of taxane-induced effects. Most importantly, we hope to provide a starting point for improving and advancing sex-specific personalized chemotherapy and cancer treatment strategies as well as to present a novel approach to review sex as a biological variable in basic and clinical biology.
Insights
Taxanes are common cancer drugs, but their effects differ between sexes. This review highlights sex-specific mechanisms and outcomes to improve personalized chemotherapy.
Area of Science:
- Oncology
- Pharmacology
- Sex Differences in Medicine
Background:
- Taxanes are widely used microtubule poisons and chemotherapeutics.
- Limited research exists on sex-specific mechanisms and toxicities of taxanes.
- Clinically observed sex-differences in taxane toxicities impact cancer patients disproportionately.
Purpose of the Study:
- To review and synthesize pre-clinical and clinical literature on taxane-induced sex-specific effects.
- To highlight uncharacterized sex-dependent mechanisms of action and clinical outcomes.
- To provide a foundation for sex-specific personalized chemotherapy strategies.
Main Methods:
- Comprehensive literature review of paclitaxel and taxane oncology studies.
- Examination of sex-discrepancies in taxane efficacy and toxicity.
- Analysis of basic and clinical data on sex dimorphisms in taxane effects.
Main Results:
- Identified significant sex-discrepancies in taxane mechanisms of action and toxicity.
- Highlighted under-researched areas of sex-dependent taxane effects.
- Summarized current knowledge on sex dimorphisms in taxane-induced outcomes.
Conclusions:
- Understanding sex as a biological variable is crucial for advancing cancer treatment.
- Sex-specific insights can improve personalized chemotherapy and cancer care.
- This review serves as a starting point for future research into sex-tailored taxane therapies.
Related Concept Videos
Drugs that Stabilize Microtubules
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Factors Affecting Drug Response: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Physical Properties of Amines

